BioXcel Therapeutics, Inc. Gains 26.19%
Thu, Feb 13, 2020 at 05:30 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) rocketted at $23.85, representing a gain of 26.2%. On Wed 12 Feb 20, BTAI:NASDAQ touched a New 2-Week Intraday High of $21.7. The stock got featured on our News Catalysts scanner on Fri 07 Feb 20 at 08:23 AM in the 'MISCELLANEOUS' category. From Thu 23 Jan 20, the stock recorded 57.14% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- FTS International, Inc. (FTSI:NYSE), 126.9%
- Genprex, Inc. (GNPX:NASDAQ), 51.38%
- Atlas Financial Holdings, Inc. (AFH:NASDAQ), 38.15%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.52%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 26.19%
- Northern Dynasty Minerals Ltd. (NAK:NYSEMKT), 25.53%
- Viveve Medical, Inc. (VIVE:NASDAQ), 24.51%
- Happiness Biotech Group Limited (HAPP:NASDAQ), 23.14%
- CounterPath Corporation (CPAH:NASDAQ), 21.86%
- EuroDry Ltd. (EDRY:NASDAQ), 21.15%